Epoetin theta is identical in its amino acid sequence and similar in its carbohydrate composition (glycosylation) to endogenous human erythropoietin. After administration of epoetin theta, the number of erythrocytes, the haematocrit values and reticulocyte counts increase.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC Group | Classification | |
|---|---|---|
| B03XA | Other antianemic preparations | B Blood and blood forming organs → B03 Antianemic preparations → B03X Other antianemic preparations |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Document | Type | Information Source | |
|---|---|---|---|
| EPORATIO Solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
Epoetin theta is an active ingredient of these brands:
Austria (AT)Croatia (HR)Cyprus (CY)
Estonia (EE)Finland (FI)
France (FR)
Germany (DE)
Ireland (IE)Lithuania (LT)Poland (PL)Spain (ES)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.